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Introduction & Aims: Small molecules can correct CFTR production or function and 
greatly improve CF outcomes. Rarer mutations are hindered by the lack of appropriate 
primary culture models. Modifying primary airway epithelial cells (AECs) from children 
with CF modified to express a fluorescence marker that allows functional CFTR 
assessment would provide a culture-based high-throughput screening platform. We 
compared methodologies to achieve stable fluorescence in primary AEC. 
 
Methods: Primary AECs were obtained from children (CF and non-CF) by bronchial 
brushing and cultured using a conditional reprogramming methodology. Cells were 
transfected with a pcDNA3.1 plasmid via Lipofectamine® or Nucleofector™ device. 
Alternatively, AEC were transduced by a replication-deficient retroviral vector with 
fluorescent tag. After 48 hours, cells expressing fluorescence were selected by 
fluorescence activated cell sorting (FACS) flow cytometry and then expanded further 
in culture to assess stability of gene expression. 
 
Results: Primary AECs were amenable to all three methodologies. Transfection by 
Lipofectamine® was 24.1% efficient and the best electroporation protocol achieved a 
slightly higher efficiency (30.0%). Replication deficient retrovirus was most effective 
with 78.9% positive cells. There was no difference in transfection efficiency observed 
between non-CF and CF AECs. Cells could be successfully cultured after FACS 
selection, but only AEC transduced by retroviral vector maintained their fluorescence 
through two passages of cultures. 
 
Conclusion: Retroviral vector could stably induce fluorescence into primary AECs. 
We are constructing a retroviral vector containing the YFP gene and validating the 
CFTR functional assay across a range of CFTR mutations. 
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